The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Five members of the Promoter/Promoter Group of Indoco Remedies have reshuffled their shareholdings through open-market transactions on August 7-8, 2025. Aditi M. Panandikar bought 20,800 shares and Madhura S. Kare bought 7,300 shares, while Megh M. Panandikar (13,000), Mahika M. Panandikar (7,800) and Rohan A. Ramani (7,300) sold their entire holdings. Total shares moved: 28,100 (0.03% of equity capital). The aggregate Promoter Group holding remains unchanged at 1,09,31,545 shares (11.85% of paid-up capital) before and after the transactions. The company's total equity share capital stayed at 9,22,47,905 shares of Rs.2 each.
This is a housekeeping reshuffle within the promoter family – no change in total promoter ownership or voting power. No material impact expected on share price or shareholder value; the disclosure is filed solely because individual holdings crossed a reporting threshold under SAST rules.